Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Subler

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Oncogene|July 22, 1998
'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domainA Lányi, D Deb, R C Seymour, et al.
Biochemical and Biophysical Research Communications|August 31, 1993
p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding proteinD W Martin, M A Subler, R M Muñoz, et al.
Molecular and Cellular Biology|February 1, 1997
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53J E Hundley, S K Koester, D A Troyer, et al.
Oncogene|March 14, 2000
Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumorsD J Bearss, M A Subler, J E Hundley, et al.
Molecular and Cellular Biology|November 1, 1996
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53J H Ludes-Meyers, M A Subler, C V Shivakumar, et al.
Molecular and Cellular Biology|January 7, 1998
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosisR E Barrington, M A Subler, E Rands, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Oncogene|July 22, 1998
'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domainA Lányi, D Deb, R C Seymour, et al.
Biochemical and Biophysical Research Communications|August 31, 1993
p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding proteinD W Martin, M A Subler, R M Muñoz, et al.
Molecular and Cellular Biology|February 1, 1997
Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53J E Hundley, S K Koester, D A Troyer, et al.
Oncogene|March 14, 2000
Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumorsD J Bearss, M A Subler, J E Hundley, et al.
Molecular and Cellular Biology|November 1, 1996
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53J H Ludes-Meyers, M A Subler, C V Shivakumar, et al.
Molecular and Cellular Biology|January 7, 1998
A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosisR E Barrington, M A Subler, E Rands, et al.
Pageof 2